0,1,2,3,4,5
,,Table 2. VACV-derived vaccines.,,,
,,,Features,,
,Pathogenic Agent,Antigen,,,Reference
,,,Site of Insertion,Reporter Gene,
,,Env,TK or HA gene,"LacZ, LUC","[90,92]"
,HIV,Env (TAB 13),HA gene,LacZ,[35]
,,RT,Not mentioned,LacZ,[93]
,,HBsAg,TK gene or BamHI site,Not mentioned,"[38,94,95]"
,,PreS2-S,TK gene,Not mentioned,[96]
,Hepatitis B virus,,,,
Viral,,LS,TK gene,Not mentioned,[97]
,,MS,TK gene,Not mentioned,[98]
,,gD,TK gene or BamHI site,Not mentioned,"[38,99,100]"
,Herpes simplex virus 1,gB,Not mentioned,Not mentioned,"[101,102]"
,,gG,Not mentioned,Not mentioned,[103]
,,HA,TK gene,Not mentioned,[104]
,Inï¬‚uenza,,,,
,,"M1, NS1, NP, PB1, PA",TK gene,Not mentioned,[105]
,Plasmodium yoelii,Circumsporozoite,TK gene,LacZ,[34]
Protist,Plasmodium knowlesi,Sporozoite antigen,TK gene,Not mentioned,[88]
,Plasmodium falciparum,S antigen,TK gene,Not mentioned,[87]
,Leishmania infantum,LACK,TK and HA gene,LacZ and GUS,[106]
Animal,Echinococcus granulosus,E95 antigen,TK gene,LacZ,[107]
,Brucella abortus,18-kDa antigen,TK gene,LacZ,[86]
Bacterial,,,,,
,Streptococcus pyogenes,M protein,TK gene,Not mentioned,[108]
